Ahmadi-Ashtiani H, Allameh A, Rastegar H, Soleimani M, Barkhordari E (2012) Inhibition of cyclooxygenase-2 and inducible nitric oxide synthase by silymarin in proliferating mesenchymal stem cells: comparison with glutathione modifiers. J Nat Med 66:85–94

Article  CAS  PubMed  Google Scholar 

Akbari Kordkheyli V, Nabipur E, Tafazoli A, Bagheri A (2018) An overview on the effects of silibinin on different microRNAs expression in cancer. Journal of Mazandaran University of Medical Sciences 28(165):213–229. http://jmums.mazums.ac.ir/article-1-11714-en.html

Alhusban A, Alkhazaleh E, El-Elimat T (2017) Silymarin ameliorates diabetes-induced proangiogenic response in brain endothelial cells through a GSK-3β inhibition-induced reduction of VEGF release. J Diabetes Res 2017:2537216

Article  PubMed  PubMed Central  Google Scholar 

Ali A, Sheikh IA, Mirza Z, Gan SH, Kamal MA, Abuzenadah AM, Damanhouri GA, Ashraf GM (2015) Application of proteomic tools in modern nanotechnological approaches towards effective management of neurodegenerative disorders. Curr Drug Metab 16:376–388

Article  CAS  PubMed  Google Scholar 

Al-Rawaf HA, Alghadir AH, Gabr SA (2021) Molecular changes in circulating microRNAs’ expression and oxidative stress in adults with mild cognitive impairment: a biochemical and molecular study. Clin Interv Aging 16:57–70

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amato A, Terzo S, Mulè F (2019) Natural compounds as beneficial antioxidant agents in neurodegenerative disorders: a focus on Alzheimer’s disease. Antioxidants 8:608

Article  CAS  PubMed  PubMed Central  Google Scholar 

An F, Gong G, Wang Y, Bian M, Yu L, Wei C (2017a) MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1. Oncotarget 8:114065–114071

Article  PubMed  PubMed Central  Google Scholar 

An F, Gong G, Wang Y, Bian M, Yu L, Wei C (2017b) MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1. Oncotarget 8:114065

Article  PubMed  PubMed Central  Google Scholar 

Anstey KJ, Lipnicki DM, Low L-F (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16:343–354

Article  PubMed  Google Scholar 

Ariaei A, Ramezani F (2023) The promising impact of Bemcentinib and Repotrectinib on sleep impairment in Alzheimer’s disease. J Biomol Struct Dyn, pp 1–17. https://doi.org/10.1080/07391102.2023.2276876

Azizi S, Hier DB, Allen B, Obafemi-Ajayi T, Olbricht GR, Thimgan MS, Wunsch DC 2nd (2021) A kinetic model for blood biomarker levels after mild traumatic brain injury. Front Neurol 12:668606

Article  PubMed  PubMed Central  Google Scholar 

Banzhaf-Strathmann J, Benito E, May S, Arzberger T, Tahirovic S, Kretzschmar H, Fischer A, Edbauer D (2014) Micro RNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer’s disease. EMBO J 33:1667–1680

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE (2014) Identification of a unique TGF-β–dependent molecular and functional signature in microglia. Nat Neurosci 17:131–143

Article  CAS  PubMed  Google Scholar 

Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33:e179

Article  PubMed  PubMed Central  Google Scholar 

Cheng AC, Coleman RG, Smyth KT, Cao Q, Soulard P, Caffrey DR, Salzberg AC, Huang ES (2007) Structure-based maximal affinity model predicts small-molecule druggability. Nat Biotechnol 25:71–75

Article  PubMed  Google Scholar 

Chtourou Y, Fetoui H, el Garoui M, Boudawara T, Zeghal N (2012) Improvement of cerebellum redox states and cholinergic functions contribute to the beneficial effects of silymarin against manganese-induced neurotoxicity. Neurochem Res 37:469–479

Article  CAS  PubMed  Google Scholar 

Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 14:399–415

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daugaard I, Hansen TB (2017) Biogenesis and function of ago-associated RNAs. Trends Genet 33:208–219

Article  CAS  PubMed  Google Scholar 

De, P., Roy, K., 2023. Computational Modeling of Kinase Inhibitors as Anti-Alzheimer Agents. Computational Modeling of Drugs Against Alzheimer’s Disease. Springer, pp. 127–163.

Dexheimer PJ, Cochella L (2020) MicroRNAs: from mechanism to organism. Front Cell Dev Biol 8:409

Article  PubMed  PubMed Central  Google Scholar 

Dong W, Vuletic S, Albers JJ (2009) Differential effects of simvastatin and pravastatin on expression of Alzheimer’s disease-related genes in human astrocytes and neuronal cells. J Lipid Res 50:2095–2102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dornan D, Settleman J (2010) Cancer: miRNA addiction—depending on life’s little things. Curr Biol 20:R812–R813

Article  CAS  PubMed  Google Scholar 

Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B (2017) Silymarin impacts on immune system as an immunomodulator: one key for many locks. Int Immunopharmacol 50:194–201

Article  CAS  PubMed  Google Scholar 

Feigin VL, Theadom A, Barker-Collo S, Starkey NJ, McPherson K, Kahan M, Dowell A, Brown P, Parag V, Kydd R, Jones K, Jones A, Ameratunga S (2013) Incidence of traumatic brain injury in New Zealand: a population-based study. Lancet Neurol 12:53–64

Article  PubMed  Google Scholar 

Feng X, Wang C, Gu Z, Ni J, Huang D, Feng G, Lian M, Lu Q, Song Y (2019) Rosuvastatin regulates odontoblast differentiation by suppressing NF-κB activation in an inflammatory environment. Cell Reprogram 21:18–25

Article  CAS  PubMed  Google Scholar 

Gaudet AD, Fonken LK, Watkins LR, Nelson RJ, Popovich PG (2018) MicroRNAs: roles in regulating neuroinflammation. Neuroscientist 24:221–245

Article  CAS  PubMed  Google Scholar 

Ge X, Guo M, Hu T, Li W, Huang S, Yin Z, Li Y, Chen F, Zhu L, Kang C, Jiang R, Lei P, Zhang J (2020) Increased microglial exosomal miR-124-3p alleviates neurodegeneration and improves cognitive outcome after rmTBI. Mol Ther 28:503–522

Article  CAS  PubMed  Google Scholar 

Grammas P, Ovase R (2002) Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer’s disease brain. Am J Pathol 160:1583–1587

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu X, Xu X, Jia C, Wang J, Zhang J, Gao Q, Chen J (2023) Molecular mechanisms involved in the regulation of neurodevelopment by miR-124. Mol Neurobiol 60:3569–3583

Guo Y, Hong W, Wang X, Zhang P, Körner H, Tu J, Wei W (2019) MicroRNAs in microglia: how do MicroRNAs affect activation, inflammation, polarization of microglia and mediate the interaction between microglia and glioma? Front Mol Neurosci 12:125

Article  PubMed  PubMed Central  Google Scholar 

Habib A, Shamseddeen I, Nasrallah MS, Antoun TA, Nemer G, Bertoglio J, Badreddine R, Badr KF (2007) Modulation of COX-2 expression by statins in human monocytic cells. Faseb J 21:1665–1674

Article  CAS  PubMed  Google Scholar 

Haddadi R, Shahidi Z, Eyvari-Brooshghalan S (2020) Silymarin and neurodegenerative diseases: therapeutic potential and basic molecular mechanisms. Phytomedicine 79:153320

Article  CAS  PubMed  Google Scholar 

Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, Huijbers W, Hedden T, Marshall GA, Chhatwal JP, Rentz DM, Sperling RA, Johnson K (2019) Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol 76:915–924

Article